New Lung-Cancer Study Sparks Controversy
A large international study looking at the use of controversial, and expensive, computed tomography (CT) scans to screen for lung cancer has determined that the technology does not reduce deaths from the disease. The finding directly conflicts with a widely publicized study from last October that estimated 80% of lung-cancer deaths could be prevented by CT screening, and has galvanized the two sides of the debate (see BusinessWeek.com, 10/25/06, "Lung Cancer: Hope for Early Detection").
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Bitcoin Futures Deliver Wild Ride as Debut Brings Rally, Halts
- Investors Told to Brace for Steepest Rate Hikes Since 2006
- A Manager of $42 Billion Fears Bubble in World's Biggest Stocks
- Longtime NPR Host Tom Ashbrook Is Facing Misconduct Allegations
- Buffett's About to Get $3 Billion Back From Burger King Owner